SEARCH

SEARCH BY CITATION

References

  • Aderinwale, O. G., Ernst, H. W., & Mousa, S. A. (2010). Current therapies and new strategies for the management of Alzheimer's disease. American Journal of Alzheimer's Disease & Other Dementias , 25(5), 414424.
  • Almoguera, B., Riveiro-Alvarez, R., Lopez-Castroman, J., Dorado, P., Vaquero-Lorenzo, C., Fernandez-Piqueras, J., … Spanish Consortium of Pharmacogenetics Research in Schizophrenia. (2012). Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population. Pharmacogenomics Journal . Retrieved from http://www.bionity.com/en/publications/330928/association-of-common-genetic-variants-with-risperidone-adverse-events-in-a-spanish-schizophrenic-population.html doi: 10.1038/tpj.2011.57
  • Alzheimer's Association. (2012). Alzheimer's disease facts and figures. Alzheimer's and Dementia: The Journal of the Alzheimer's Association , 8, 131168.
  • American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington , DC : Author.
  • Arendash, G. W., Garcia, M. F., Costa, D. A., Cracchiolo, J. R., Wefes, I. M., & Potter, H. (2004). Environmental enrichment improves cognitive function in aged Alzheimer's transgenic mice despite stable-β-amyloid deposition. Neuroreport , 15, 17511754.
  • Arranz, M. J., Rivera, M., & Munro, J. C. (2011). Pharmacogenetics of response to antipsychotics in patients with schizophrenia. CNS Drugs , 25(11), 933969.
  • Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nature Genetics , 39(1), 1723.
  • Bienvenu, O. J., Davydow, D. S., & Kendler, K. S. (2011). Psychiatric “diseases” versus behavioral disorders and degree of genetic influence. Psychological Medicine , 41(1), 3340.
  • Bird, T. D. (2010). Alzheimer disease overview. GeneReviews . Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK1161/
  • Bleakley, B. H., & Brodie, E. D., 3rd. (2009). Indirect genetic effects influence antipredator behavior in guppies: Estimates of the coefficient of interaction psi and the inheritance of reciprocity. Evolution , 63(7), 17961806.
  • Borgaonkar, D., Schmidt, L., Martin, S., Kanzer, M., Edelsohn, L., Growdon, J., et al. (1993). Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 allele on chromosome 19. Lancet , 342(8871). Retrieved from http://www.thelancet.com/journals/lancet/article/PII0140-6736(93)91458-X/fulltext#
  • Breen, G., Webb, B. T., Butler, A. W., van den Oord, E. J., Tozzi, F., Craddock, N., McGuffin, P. (2011). A genome-wide significant linkage for severe depression on chromosome 3: The depression network study. American Journal of Psychiatry , 168(8), 840847.
  • Brown, A. S. (2011). The environment and susceptibility to schizophrenia. Progress in Neurobiology , 93(1), 2358.
  • Campion, E., Dumanchin, C., Hannequin, D., Dubois, B., Belliard, S., Puel, M., & Frebourg, T. (1999). Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum. American Journal of Human Genetics , 65(3), 664177.
  • Carasquillo, M. M., Belbin, O., Hunter, T. A., Ma, L., Bisceglio, G. D., Zou, F., Younkin, S. G. (2010). Replication of CLU, CR1, and PICALM with Alzheimer's disease. Archives of Neurology , 67, 961964.
  • Charych, E. I., Liu, F., Moss, S. J., & Brandon, N. J. (2009). GABA(A) receptors and their associated proteins: Implications in the etiology and treatment of schizophrenia and related disorders. Neuropharmacology , 57(5–6), 481495.
  • Chen, D. T., Jiang, X., Akula, N., Shugart, Y. Y., Wendland, J. R., Steele, C. J., McMahon, F. J. (2011). Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Molecular Psychiatry . Retrieved from http://www.nature.com/mp/journal/vaop/ncurrent/full/mp2011157a.html
  • Cherlyn, S. Y., Woon, P. S., Liu, J. J., Ong, W. Y., Tsai, G. C., & Sim, K. (2010). Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: A decade of advance. Neuroscience and Biobehavioral Reviews , 34(6), 958977.
  • Cichon, S., Craddock, N., Daly, M., Faraone, S. V., Gejman, P. V., Kelsoe, J., Sullivan, P. F. (2009). Genomewide association studies: History, rationale, and prospects for psychiatric disorders. American Journal of Psychiatry , 166(5), 540556.
  • Corder, E., Saunders, A., Strittmatter, W., Schmechel, D., Gaskell, P., Small, G., Pericak-Vance, M. A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science , 261(5123), 923927.
  • Daray, F. M., Thommi, S. B., & Ghaemi, S. N. (2010). The pharmacogenetics of antidepressant-induced mania: A systematic review and meta-analysis. Bipolar Disorders , 12(7), 702706.
  • De la Vega, F. M., Bustamante, C. D., & Leal, S. M. (2011). Genome-wide association mapping and rare alleles from population genomics to personalized medicine—Session introduction. Pacific Symposium on Biocomputing , 7475.
  • de Leon, J. (2009). Pharmacogenomics: The promise of personalized medicine for CNS disorders. Neuropsychopharmacology , 34(1), 159172.
  • Drago, A., Crisafulli, C., & Serretti, A. (2011). The genetics of antipsychotic induced tremors: A genome-wide pathway analysis on the STEP-BD SCP sample. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics , 156B(8), 975986.
  • Drago, A., Crisafulli, C., Sidoti, A., & Serretti, A. (2011). The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes. Progress in Neurobiology , 94(4), 418460.
  • Elder, B. L., & Mosack, V. (2011). Genetics of depression: An overview of the current science. Issues in Mental Health Nursing , 32, 192202.
  • Gejman, P. V., Sanders, A. R., & Kendler, K. S. (2011). Genetics of schizophrenia: New findings and challenges. Annual Review of Genomics and Human Genetics , 12, 121144.
  • Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Hardy, J. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature , 349(6311), 704706.
  • Grof, P. (2010). Sixty years of lithium responders. Neuropsychobiology , 62(1), 816.
  • Hamdani, N., Tamouza, R., & Leboyer, M. (2012). Immuno-inflammatory markers of bipolar disorder: A review of evidence. Frontiers in Bioscience (Elite Edition) , 4, 21702182.
  • Hasler, G., & Northoff, G. (2011). Discovering imaging endophenotypes for major depression. Molecular Psychiatry , 16(6), 604619.
  • Hendset, M., Hermann, M., Lunde, H., Refsum, H., & Molden, E. (2007). Impact of the CYP2D6 genotype on steady-state serum concentrations of aripiprazole and dehydroaripiprazole. European Journal of Clinical Pharmacology , 63(12), 11471151.
  • Huntington's Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell , 72, 971983.
  • Ising, M., Lucae, S., Binder, E.B., Bettecken, T., Uhr, M., Ripke, S., Müller-Myhsok, B. (2009). A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Archives of General Psychiatry , 66(9), 966975.
  • Ivleva, E. I., Morris, D. W., Moates, A. F., Suppes, T., Thaker, G. K., & Tamminga, C. A. (2010). Genetics and intermediate phenotypes of the schizophrenia–bipolar disorder boundary. Neuroscience and Biobehavioral Reviews , 34(6), 897921.
  • Jenkins, J., & Calzone, K. A. (2007). Establishing the essential nursing competencies for genetics and genomics. Journal of Nursing Scholarship , 39(1), 1016.
  • Kato, M., & Serretti, A. (2010). Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Molecular Psychiatry , 15(5), 473500.
  • Kendler, K. S. (2001). Twin studies of psychiatric illness: An update. Archives of General Psychiatry , 58(11), 10051014.
  • Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., Kendler, K. S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry , 51(1), 819.
  • Kim, B., Kim, C. Y., Lee, M. J., & Joo, Y. H. (2009). Preliminary evidence on the association between XBP1–116C/G polymorphism and response to prophylactic treatment with valproate in bipolar disorders. Psychiatric Research , 168(3), 209212.
  • Kozuki, Y., & Schepp, K. G. (2005). Adherence and nonadherence to antipsychotic medications. Issues in Mental Health Nursing , 26(4), 379396.
  • Langbehn, D. R., Hayden, M. R., & Paulsen, J. S. (2010). CAG-repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics , 153B, 397408.
  • Lau, J. Y., & Eley, T. C. (2010). The genetics of mood disorders. Annual Review of Clinical Psychology , 6, 313337.
  • Lett, T. A., Wallace, T. J., Chowdhury, N. I., Tiwari, A. K., Kennedy, J. L., & Muller, D. J. (2012). Pharmacogenetics of antipsychotic-induced weight gain: Review and clinical implications. Molecular Psychiatry , 17(3), 242266.
  • Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Tanzi, R. E. (1995). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science , 269(5226), 973977.
  • Lohoff, F. W. (2010). Overview of the genetics of major depressive disorder. Current Psychiatry Reports , 12(6), 539546.
  • Malhotra, A. K., Zhang, J. P., & Lencz, T. (2011). Pharmacogenetics in psychiatry: Translating research into clinical practice. Molecular Psychiatry , 17(8), 760769.
  • Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., Visscher, P. M. (2009). Finding the missing heritability of complex diseases. Nature , 8, 747753.
  • McMahon, F. J., Akula, N., Schulze, T. G., Muglia, P., Tozzi, F., Detera-Wadleigh, S. D., … Bipolar Disorder Genome Study (BiGS) Consortium. (2010). Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nature Genetics , 42(2), 128131.
  • Mitchell, P. B., Meiser, B., Wilde, A., Fullerton, J., Donald, J., Wilhelm, K., & Schofield, P. R. (2010). Predictive and diagnostic genetic testing in psychiatry. Psychiatric Clinics of North America , 33(1), 225243.
  • Mullan, M., Houlden, H., Windelspecht, M., Fidani, L., Lombardi, C., Diaz, P., Crawford, F. (1992). A locus for familial early-onset Alzheimer's disease in the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nature Genetics , 2(4), 340342.
  • National Institute on Aging, U.S. National Institutes of Health, Alzheimer's Disease Education & Referral Center. (2010). Alzheimer's information . Retrieved from http://www.nia.nih.gov/Alzheimers/Alz
  • Nugent, N. R., Tyrka, A. R., Carpenter, L. L., & Price, L. H. (2011). Gene-environment interactions: Early life stress and risk for depressive and anxiety disorders. Psychopharmacology (Berl) , 214(1), 175196.
  • O’Connell, G., Lawrie, S. M., McIntosh, A. M., & Hall, J. (2011). Schizophrenia risk genes: Implications for future drug development and discovery. Biochemical Pharmacology , 81(12), 13671373.
  • Online Mendelian Inheritance in Man. (2011). 107741 APOLIPOPROTEIN E; APOE . Retrieved from http://omim.org/entry/107741
  • Peltonen, L., Palotie, A., & Lange, K. (2000). Use of population isolates for mapping complex traits. Nature Review Genetics , 1(3), 182190.
  • Pergadia, M. L., Glowinski, A. L., Wray, N. R., Agrawal, A., Saccone, S. F., Loukola, A., Gejman, P. V. (2011). A 3p26–3p25 genetic linkage finding for DSM-IV major depression in heavy smoking families. American Journal of Psychiatry , 168(8), 848852.
  • Pericak-Vance, M. A., Beboutt, L., Gaskell, P. C., Yamaokat, L. H., Hung, W.-Y., Alberts, M. J., Roses, A. D. (1991). Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage. American Journal of Human Genetics , 48, 10341050.
  • Perroud, N. (2011). Suicidal ideation during antidepressant treatment: Do genetic predictors exist CNS Drugs , 25(6), 459471.
  • Porcelli, S., Drago, A., Fabbri, C., Gibiino, S., Calati, R., & Serretti, A. (2011). Pharmacogenetics of antidepressant response. Journal of Psychiatry & Neuroscience , 36(2), 87113.
  • Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O’Donovan, M. C., Sullivan, P. F., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature , 460(7256), 748752.
  • Ripke, S., Sanders, A. R., Kendler, K. S., Levinson, D. F., Sklar, P., Holmans, P. A., et al. (2011). Genome-wide association study identifies five new schizophrenia loci. Nature Genetics , 43(10), 969976.
  • Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., St. George-Hyslop, P. (2007). The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer's disease. Nature Genetics , 39(2), 168177.
  • Roses, A. D., Lutz, M. W., Amrine-Madsen, H., Saunders, A. M., Crenshaw, D. G., Sundseth, S. S., Reiman, E. M. (2010). A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics Journal , 10(5), 375384.
  • Rudberg, I., Mohebi, B., Hermann, M., Refsum, H., & Molden, E. (2008). Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients. Clinical Pharmacology and Therapeutics , 83(2), 322327.
  • Scharinger, C., Rabl, U., Pezawas, L., & Kasper, S. (2011). The genetic blueprint of major depressive disorder: Contributions of imaging genetics studies. World Journal of Biological Psychiatry , 12(7), 474488.
  • Schulze, T. G., Alda, M., Adli, M., Akula, N., Ardau, R., Bui, E. T., McMahon, F. J. (2010). The International Consortium on Lithium Genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology , 62(1), 7278.
  • Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe’er, I., Gejman, P. V. (2009). Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature , 460(7256), 753757.
  • Smeraldi, E., Bellodi, L., & Cazzullo, C. L. (1976). Further studies on the major histocompatibility complex as a genetic marker for schizophrenia. Biological Psychiatry , 11(6), 655661.
  • Steimer, W. (2010). Pharmacogenetics and psychoactive drug therapy: Ready for the patient Therapeutic Drug Monitoring , 32(4), 381386.
  • Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Collier, D. A. (2009). Common variants conferring risk of schizophrenia. Nature , 460(7256), 744747.
  • Sullivan, P. F., de Geus, E. J., Willemsen, G., James, M. R., Smit, J. H., Zandbelt, T., Penninx, B. W. J. H. (2009). Genome-wide association for major depressive disorder: A possible role for the presynaptic protein piccolo. Molecular Psychiatry , 14(4), 359375.
  • U.S. Department of Agriculture. (2005). FDA Public Health Advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances . Retrieved September 22, 2012, from http://www.fda.gov/cder/drug/advisory/antipsychotics.htm
  • Warby, S. C., Graham, R. K., & Hayden, M. R. (2010, April 22). Huntington disease. GeneReviews . Retrieved March 22, 2012, from http://www.ncbi.nlm.nih.gov/books/NBK1305/
  • World Health Organization. (2012). Dementia: A public health priority. Geneva , Switzerland : Author.
  • Wray, N. R., Pergadia, M. L., Blackwood, D. H., Penninx, B. W., Gordon, S. D., Nyholt, D. R., Sullivan, P. F. (2012). Genome-wide association study of major depressive disorder: New results, meta-analysis, and lessons learned. Molecular Psychiatry , 17(1), 3648.
  • Zeggini, E. (2011). Next-generation association studies for complex traits. Nature Genetics , 43(4), 287288.
  • Zhang, J. P., Lencz, T., & Malhotra, A. K. (2010). D2 receptor genetic variation and clinical response to antipsychotic drug treatment: A meta-analysis. American Journal of Psychiatry , 167(7), 763772.